Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft...
- Mechanism
- Curator reviewed
Cefonicid, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins.
- Primary indication
- For the treatment of bacterial infections caused by susceptible microorganisms.Curator reviewed
- Formula / weight
- C18H18N6O8S3 · 542.566 g/mol (avg)
Resolves to
DYAIAHUQIPBDIP-AXAPSJFSSA-NSMILES[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=OWhat you can answer from here — as of September 13, 2026
Which drugs share a target with Cefonicid, and which of those have an active Phase 3 trial?